ArticleMolecular therapy : the journal of the American Society of Gene Therapy2023

Chimeric TIM-4 receptor-modified T cells targeting phosphatidylserine mediates both cytotoxic anti-tumor responses and phagocytic uptake of tumor-associated antigen for T cell cross-presentation.

Brandon Cieniewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.